Your browser doesn't support javascript.
loading
Perfluoroarene-Based Peptide Macrocycles to Enhance Penetration Across the Blood-Brain Barrier.
Fadzen, Colin M; Wolfe, Justin M; Cho, Choi-Fong; Chiocca, E Antonio; Lawler, Sean E; Pentelute, Bradley L.
Affiliation
  • Fadzen CM; Department of Chemistry, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.
  • Wolfe JM; Department of Chemistry, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.
  • Cho CF; Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts 02115, United States.
  • Chiocca EA; Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts 02115, United States.
  • Lawler SE; Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts 02115, United States.
  • Pentelute BL; Department of Chemistry, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.
J Am Chem Soc ; 139(44): 15628-15631, 2017 11 08.
Article in En | MEDLINE | ID: mdl-28992407
Here we describe the utility of peptide macrocyclization through perfluoroaryl-cysteine SNAr chemistry to improve the ability of peptides to cross the blood-brain barrier. Multiple macrocyclic analogues of the peptide transportan-10 were investigated that displayed increased uptake in two different cell lines and improved proteolytic stability. One of these analogues (M13) exhibited substantially increased delivery across a cellular spheroid model of the blood-brain barrier. Through ex vivo imaging of mouse brains, we demonstrated that this perfluoroarene-based macrocycle of TP10 exhibits increased penetration of the brain parenchyma following intravenous administration in mice. Finally, we evaluated macrocyclic analogues of the BH3 domain of the BIM protein to assess if our approach would be applicable to a peptide of therapeutic interest. We identified a BIM BH3 analogue that showed increased penetration of the brain tissue in mice.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Peptides / Blood-Brain Barrier / Macrocyclic Compounds Limits: Animals Language: En Journal: J Am Chem Soc Year: 2017 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Peptides / Blood-Brain Barrier / Macrocyclic Compounds Limits: Animals Language: En Journal: J Am Chem Soc Year: 2017 Type: Article Affiliation country: United States